Viewing Study NCT06440993


Ignite Creation Date: 2025-12-25 @ 12:56 AM
Ignite Modification Date: 2026-02-17 @ 10:51 PM
Study NCT ID: NCT06440993
Status: RECRUITING
Last Update Posted: 2025-12-01
First Post: 2024-05-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Durvalumab + Intraductal Radiofrequency Ablation (ID-RFA) in Extrahepatic Cholangiocarcinoma
Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module